In part 2 of this video interview, Diane Lacroix, vice president, clinical data management, eClinical Solutions highlights how artificial intelligence can help industry keep pace with the increasing complexity of data.
ACT: How can data management challenges be addressed? Specifically, is there any opportunity to address them with artificial intelligence (AI)?
Lacroix: There is a lot of opportunity across the life cycle to assist with this and it's interesting because historically it was always: we want to throw people at some of these problems. I think it's important to mention that people are not always the answer. Specifically in data management, there's a shortage of resources. There's a shortage of resources with the appropriate skill sets to manage the complexity, so we really do need to look at innovative processes and technologies to assist with managing this complexity; AI is one of those. When we're talking about all of the data and the high volume of data coming in, and specifically these adaptive trial designs, AI can help us with processing those large volumes of data to be able to automate and we need to build in automation for ingestion of these continual data flows, and utilize artificial intelligence to help us interrogate that data to be able to gain those insights, specifically around these adaptive trials, because of the ongoing decision making that happens throughout the course of these trials.
Utilizing automation is what we do at eClinical Solutions, as far as automating all those data sources into a clinical data management platform, elluminate, where the tool and the technology helps us to not only ingest, but to standardize and harmonize that data in a way that unifies that data so that we can look at that data more holistically and cohesively for that decision making for these adaptive trials. The data cleaning part of it is specifically for data management, it’s a big area that this can help with. As these large volumes of data continue to grow, we can't continue to throw edit checks at it or line listings at it. We need to use more smart and innovative tools to be able to process and interrogate that data.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
SCOPE Summit 2025: Enhancing the Patient Experience Through Site Centricity
February 12th 2025In an interview with ACT senior editor Andy Studna at SCOPE Summit, Ashley Davidson, vice president, product lead - sponsor tech strategy, Advarra, highlights the need for more site-centric approaches in study startup.